Monday, December 5, 2016

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 1

If you are unable to see the message below, click here to view.


Volume 42, Issue 1 (January 2017)

In this issue
Review Articles
Hot Topics

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness

Andrew H Miller, Ebrahim Haroon and Jennifer C Felger

Neuropsychopharmacology 2017 42: 1-4; 10.1038/npp.2016.229

Full Text

Review Articles


Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance

Charles L Raison and Andrew H Miller

Neuropsychopharmacology 2017 42: 5-27; advance online publication, September 15, 2016; 10.1038/npp.2016.194

Abstract | Full Text

Central Nervous System: (Immunological) Ivory Tower or Not?

Ioana A Marin and Jonathan Kipnis

Neuropsychopharmacology 2017 42: 28-35; advance online publication, July 11, 2016; 10.1038/npp.2016.122

Abstract | Full Text

Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders

Monika Fleshner, Matthew Frank and Steven F Maier

Neuropsychopharmacology 2017 42: 36-45; advance online publication, July 14, 2016; 10.1038/npp.2016.125

Abstract | Full Text

Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal

Michael D Weber, Jonathan P Godbout and John F Sheridan

Neuropsychopharmacology 2017 42: 46-61; advance online publication, June 20, 2016; 10.1038/npp.2016.102

Abstract | Full Text

Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience

Caroline Ménard, Madeline L Pfau, Georgia E Hodes and Scott J Russo

Neuropsychopharmacology 2017 42: 62-80; advance online publication, June 13, 2016; 10.1038/npp.2016.90

Abstract | Full Text

Genetic Contributions of Inflammation to Depression OPEN

Jacob Barnes, Valeria Mondelli and Carmine M Pariante

Neuropsychopharmacology 2017 42: 81-98; advance online publication, August 24, 2016; 10.1038/npp.2016.169

Abstract | Full Text

Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma?

Andrea Danese and Stephanie J Lewis

Neuropsychopharmacology 2017 42: 99-114; advance online publication, September 15, 2016; 10.1038/npp.2016.198

Abstract | Full Text

Role of Adiposity-Driven Inflammation in Depressive Morbidity

Lucile Capuron, Julie Lasselin and Nathalie Castanon

Neuropsychopharmacology 2017 42: 115-128; advance online publication, July 11, 2016; 10.1038/npp.2016.123

Abstract | Full Text

Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity

Michael R Irwin and Mark R Opp

Neuropsychopharmacology 2017 42: 129-155; advance online publication, August 11, 2016; 10.1038/npp.2016.148

Abstract | Full Text

Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse

Michael J Lacagnina, Phillip D Rivera and Staci D Bilbo

Neuropsychopharmacology 2017 42: 156-177; advance online publication, July 11, 2016; 10.1038/npp.2016.121

Abstract | Full Text

Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome

Timothy G Dinan and John F Cryan

Neuropsychopharmacology 2017 42: 178-192; advance online publication, June 20, 2016; 10.1038/npp.2016.103

Abstract | Full Text

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders

Ebrahim Haroon, Andrew H Miller and Gerard Sanacora

Neuropsychopharmacology 2017 42: 193-215; advance online publication, September 15, 2016; 10.1038/npp.2016.199

Abstract | Full Text

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine

Jennifer C Felger and Michael T Treadway

Neuropsychopharmacology 2017 42: 216-241; advance online publication, August 2, 2016; 10.1038/npp.2016.143

Abstract | Full Text

In Sickness and in Health: The Co-Regulation of Inflammation and Social Behavior

Naomi I Eisenberger, Mona Moieni, Tristen K Inagaki, Keely A Muscatell and Michael R Irwin

Neuropsychopharmacology 2017 42: 242-253; advance online publication, August 2, 2016; 10.1038/npp.2016.141

Abstract | Full Text

Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond

Vasiliki Michopoulos, Abigail Powers, Charles F Gillespie, Kerry J Ressler and Tanja Jovanovic

Neuropsychopharmacology 2017 42: 254-270; advance online publication, August 11, 2016; 10.1038/npp.2016.146

Abstract | Full Text

Role of Inflammation in Suicide: From Mechanisms to Treatment

Lena Brundin, Elena Y Bryleva and Keerthi Thirtamara Rajamani

Neuropsychopharmacology 2017 42: 271-283; advance online publication, July 5, 2016; 10.1038/npp.2016.116

Abstract | Full Text

The Role of the Immune System in Autism Spectrum Disorder

Amory Meltzer and Judy Van de Water

Neuropsychopharmacology 2017 42: 284-298; advance online publication, August 18, 2016; 10.1038/npp.2016.158

Abstract | Full Text

Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

Brian J Miller and David R Goldsmith

Neuropsychopharmacology 2017 42: 299-317; advance online publication, September 22, 2016; 10.1038/npp.2016.211

Abstract | Full Text

Microglia Priming with Aging and Stress

Anzela Niraula, John F Sheridan and Jonathan P Godbout

Neuropsychopharmacology 2017 42: 318-333; advance online publication, September 8, 2016; 10.1038/npp.2016.185

Abstract | Full Text

Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation

Andrew H Miller, Ebrahim Haroon and Jennifer C Felger

Neuropsychopharmacology 2017 42: 334-359; advance online publication, August 24, 2016; 10.1038/npp.2016.167

Abstract | Full Text

Hot Topics


Dissecting Suicidality Using a Combined Genomic and Clinical Approach

Alexander B Niculescu and Helen Le-Niculescu

Neuropsychopharmacology 2017 42: 360; 10.1038/npp.2016.228

Full Text

Food Addiction and Obesity

Carrie R Ferrario

Neuropsychopharmacology 2017 42: 361; 10.1038/npp.2016.221

Full Text

The Emerging Role of Innate Immunity in Alzheimer’s Disease

Deepak Kumar Vijaya Kumar and Robert D Moir

Neuropsychopharmacology 2017 42: 362; 10.1038/npp.2016.226

Full Text

Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines

Rodrigo Escalona and Jan Fawcett

Neuropsychopharmacology 2017 42: 363; 10.1038/npp.2016.217

Full Text

Modeling the Impact of Social Contact on Substance Use

Mark A Smith and Justin C Strickland

Neuropsychopharmacology 2017 42: 364; 10.1038/npp.2016.218

Full Text

Impact on Cortical Function of Cocaine Abuse Co-Occurring with HIV

T Celeste Napier

Neuropsychopharmacology 2017 42: 365; 10.1038/npp.2016.222

Full Text

Mirror Neurons in Psychiatric Disorders: from Neuroception to Bio-behavioral System Dysregulation

Amedeo Minichino and Kristin Cadenhead

Neuropsychopharmacology 2017 42: 366; 10.1038/npp.2016.220

Full Text

The Cannabinoid Receptor 1 as a Key Mediator of Adolescent Behavior

Rainer Spanagel and Falk Kiefer

Neuropsychopharmacology 2017 42: 367; 10.1038/npp.2016.159

Full Text

Prospects for Medications to Reverse Causative Epigenetic Processes in Neuropsychiatry Disorders

Moshe Szyf

Neuropsychopharmacology 2017 42: 367-368; 10.1038/npp.2016.219

Full Text

Ketamine Mechanism of Action: Separating the Wheat from the Chaff

Todd D Gould, Panos Zanos and Carlos A Zarate, Jr

Neuropsychopharmacology 2017 42: 368-369; 10.1038/npp.2016.210

Full Text

The Direct and Indirect Pathways of the Nucleus Accumbens are not What You Think

Yonatan M Kupchik and Peter W Kalivas

Neuropsychopharmacology 2017 42: 369-370; 10.1038/npp.2016.160

Full Text

Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder

Francesc Artigas and Analia Bortolozzi

Neuropsychopharmacology 2017 42: 371; 10.1038/npp.2016.182

Full Text

Error Processing in Depressive States: A Translational Opportunity?

Diego A Pizzagalli and William A Carlezon

Neuropsychopharmacology 2017 42: 372; 10.1038/npp.2016.183

Full Text

Imaging Adult Hippocampal Neurogenesis In Vivo

Jeremy S Biane and Mazen A Kheirbek

Neuropsychopharmacology 2017 42: 373; 10.1038/npp.2016.200

Full Text

Emerging Epigenetic Therapies in Neuroscience: Focus on Bromodomain-Containing Drug Targets

Claes Wahlestedt

Neuropsychopharmacology 2017 42: 374; 10.1038/npp.2016.203

Full Text

REM Sleep on It!

Richard Boyce and Antoine Adamantidis

Neuropsychopharmacology 2017 42: 375; 10.1038/npp.2016.227

Full Text

The Neuroimmune Basis of Excessive Alcohol Consumption

Jody Mayfield and R Adron Harris

Neuropsychopharmacology 2017 42: 376; 10.1038/npp.2016.177

Full Text

Oxytocin-Augmented Psychotherapy: Beware of Context

René Hurlemann

Neuropsychopharmacology 2017 42: 377; 10.1038/npp.2016.188

Full Text

A Self-Generated Environmental Factor as a Potential Contributor to Atypical Early Social Communication in Autism

Takefumi Kikusui and Noboru Hiroi

Neuropsychopharmacology 2017 42: 378; 10.1038/npp.2016.225

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: